Agilent director granted 817 shares at $146.85

A non-employee director of Agilent received a fully vested stock award and now holds shares both directly and through a family trust.

Rhea-AI Filing Summary

AGILENT TECHNOLOGIES, INC. (symbol: A) is the issuer of record for a Form 4 filing submitted to the SEC. Boehnlein Glenn S reported acquisition or exercise transactions in this Form 4 filing.

AGILENT TECHNOLOGIES, INC. (A) reported that director Glenn S. Boehnlein received an award of 817 shares of common stock on September 8, 2026, described as common stock for Non-Employee Directors that is fully vested upon grant at a reference value of $146.85 per share. Following this grant, Boehnlein holds 817 shares directly, and an additional 35 shares are held indirectly through the Boehnlein 2017 Trust, for which Glenn and Susan Boehnlein serve as trustees. No transactions were reported under a Rule 10b5-1 trading plan.

Insider Trade Summary

Grant/Award: 817 shares

Grant/Award 2 txns

Insider Boehnlein Glenn S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	817	$146.85	$120K
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 817 shares (Direct); Common Stock — 35 shares (Indirect, Boehnlein 2017 Trust)

Footnotes (2)

1. F1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.
2. F2. Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees.

Key Figures

Director stock award: 817 shares Award reference price per share: $146.85 per share Direct holdings after transaction: 817 shares +1 more

4 metrics

Director stock award 817 shares Common stock for Non-Employee Directors granted September 8, 2026

Award reference price per share $146.85 per share Value reported for the 817-share common stock award

Direct holdings after transaction 817 shares Agilent common stock held directly by Glenn S. Boehnlein after the award

Indirect holdings via Boehnlein 2017 Trust 35 shares Agilent common stock held indirectly with Glenn and Susan Boehnlein as trustees

Key Terms

Non-Employee Directors, fully vested upon grant, indirect ownership, trustees

4 terms

Non-Employee Directors regulatory

"common stock for Non-Employee Directors that are fully vested upon grant"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

fully vested upon grant financial

"common stock for Non-Employee Directors that are fully vested upon grant"

indirect ownership financial

"Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees"

trustees financial

"Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees"

Trustees are people or a small group legally appointed to hold and manage assets, documents, or obligations on behalf of others and must act in those beneficiaries’ best interests. Think of them as a neutral guardian or custodian who enforces rules, protects assets, and makes decisions that can affect payments, corporate governance, or recovery in a default — all of which directly influence investor returns and risk.

FAQ

What insider transaction did Agilent (A) report for Glenn S. Boehnlein?

Agilent reported that director Glenn S. Boehnlein acquired 817 shares of common stock on September 8, 2026, from an award for Non-Employee Directors that is fully vested upon grant.

At what value was the Agilent (A) director stock award recorded?

The 817-share award to director Glenn S. Boehnlein was reported at $146.85 per share, reflecting the reference price used for the fully vested common stock grant.

How many Agilent (A) shares does Glenn S. Boehnlein hold directly after this Form 4?

After the reported award, Glenn S. Boehnlein holds 817 shares of Agilent common stock directly, as shown in the post-transaction holdings on the Form 4.

What is the Boehnlein 2017 Trust’s relationship to Agilent (A) shares?

The Form 4 states that 35 shares of Agilent common stock are held by the Boehnlein 2017 Trust, for which Glenn and Susan Boehnlein are the trustees, and these shares are reported as indirect ownership.

Was the Agilent (A) director’s stock award made under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, and there is no footnote indicating that the 817-share award was made pursuant to a Rule 10b5-1 trading plan.

Is the Agilent (A) director stock award immediately exercisable or restricted?

The footnote explains that the shares were acquired from an award of Agilent common stock for Non-Employee Directors that is fully vested upon grant, meaning no vesting schedule is described beyond the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 08:52 AM Accepted by SEC EDGAR 09/10/2026 - 08:52 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boehnlein Glenn S

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD.

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		A		817	A	$146.85(1)	817	D
Common Stock								35	I	Boehnlein 2017 Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

2. Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees.

	/s/ Shirley Qin, attorney-in-fact for Mr. Boehnlein	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)